Susceptibility assays of Candida tropicalis to miconazole

Journal of Microbiological Methods

Volumn 30, Issue 3, 1997, Pages 221-229

  Simonetti, N ^a   Simonetti, G ^a   Strippoli, V ^a   Callari, A ^a   Tecca, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Candida tropicalis; Imidazole drugs; Resistance

Indexed keywords

DOCUSATE SODIUM; IMIDAZOLE; IMIDAZOLE DERIVATIVE; MICONAZOLE; MICONAZOLE NITRATE;

AGAR GEL DIFFUSION; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA TROPICALIS; CONTROLLED STUDY; CULTURE MEDIUM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

EID: 0030869351     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7012(97)00072-9     Document Type: Article

References (42)

1. N.H. Georgopapadakou, T.J. Walsh, Antifungal agents: chemotherapeutic targets and immunologic strategies, Antimicrob. Agents Chemother. 40 (1996) 279-291.
2. D.W. Warnock, Azole drug resistance in Candida species, J. Med. Microbiol. 37 (1992) 225-226.
3. B.J. Horowitz, S.W. Edelstein, L. Lippman, Candida tropicalis vulvovaginitis, Obstet. Gynecol. 2 (1985) 229-232.
4. A. Arias, M.P. Arevalo, A. Andreu, C. Rodriguez, A. Sierra, In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents, Mycoses 37 (1994) 285-289.
5. W.G. Merz, G.R. Sandford, Isolation and characterization of a polyene resistant variant of Candida tropicalis, J. Clin. Microbiol. 9 (1979) 677-680.
6. Goodman and Gilman's The Pharmacological Basis of Therapeutics, VI ed., McMillan, London, 1980, 982 p.
7. F.C. Odds, Candida and Candidosi, II ed., Balliere Tindall, London, 1988, 294 p.
8. G. Simonetti, S. Baffa, N. Simonetti, Overcoming imidazole resistance in E. coli, J. Chemother. 8 (1996) 201-207.
9. D. Kerridge, Mode of action of clinically important antifungal drugs, Adv. Microbiol. Physiol. 27 (1986) 1-72.
10. H. Yamaguchi, Antagonistic action of lipid components of membranes from Candida albicans and various other lipids on two imidazole antimycotics, clotrimazole and miconazole, Antimicrob. Agents Chemother. 12 (1977) 16-25.
11. H. Yamaguchi, Protection by unsaturated lecithin against the imidazole antimycotics, clotrimazole and miconazole, Antimicrob. Agents Chemother. 13 (1978) 423-426.
12. F.D. D'Auria, N. Simonetti, V. Strippoli, Increased itraconazole antifungal activity by agar diffusion test, J. Microbiol. Methods 20 (1994) 47-54.
13. F.D. D'Auria, N. Simonetti, V. Strippoli, Sodium dioctylsulfosuccinate (SDSS) increases the sensitivity of Candida albicans to miconazole sulfosalicylate, Eur. Bull. Drug Res. 1 (1992) 32-36.
14. B.H. Cooper, M. Silva Hutnor, Yeast of medical importance, in: E.H. Lennette, A. Balows, W.J. Hausler, H.J. Shadomy (Eds.), Manual of Clinical Microbiology, 4th edn., American Society for Microbiology, Washington, DC, 1985, pp. 526-542.
15. K.C. Hazen, B.J. Plotkin, D.M. Klimas, Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata. Infect. Immun. 54 (1986) 269-271.
16. M. Rosenberg, D. Gutnick, E. Rosenberg, Adherence of bacteria to hydrocarbons: a simple method for measuring cell surface hydrophobicity, FEMS Microbiol. Lett. 9 (1980) 29-33.
17. N. Simonetti, F.D. D'Auria, V. Strippoli, Increased in vitro sensitivity of Candida albicans to fluconazole. Chemotherapy 37 (1991) 32-37.
18. P. Sandven, A. Bjorneklett, A. Maeland, the Norwegian Yeast Study Group, Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance, Antimicrob. Agents Chemother. 37 (1993) 2443-2448.
19. V. Strippoli, F.D. D'Auria, N. Simonetti, In vitro antimicrobial activity of econazole and miconazole sulfosalicylate, Drugs Exp. Clin. Res. 16 (1990) 237-242.
20. M. Ruhnke, A. Eigler, I. Tennagen, B. Geiseler, E. Engelmann, M. Trautmann, Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection, J. Clin. Microbiol. 32 (1994) 2092-2098.
21. D.A. Goff, S.L. Koletar, W.J. Buesching, J. Barnishan, R.J. Fass, Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles, Clin. Infect. Dis. 20 (1995) 77-83.
22. M.E. Lynch, J.D. Sobel, Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates, J. Med. Vet. Mycol. 32 (1994) 267-274.
23. A. White, M.B. Goetz, Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review, Clin. Infect. Dis. 19 (1994) 687-692.
24. A. Favel, M. Liebermann, A. Michel-Nguyen, P. Regli, Fluconazole susceptibility testing of Candida species: a comparative study of RPMI, high resolution and casitone media, J. Mycol. Med. 5 (1995) 7-12.
25. E.M. Johnson, D.W. Warnock, J. Luker, S.R. Porter, C. Scully, Emergence of azoles drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis, J. Antimicrob. Chemother. 35 (1995) 103-114.
26. P.J. Gallagher, D.E. Bennett, M.C. Henman, R.J. Russel, S.R. Flint, D.B. Shanley, D.C. Coleman, Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation, J. Gen. Microbiol. 138 (1992) 1901-1911.
27. H.V. Bossche, P. Marichal, F.C. Odds, L. Le Jeune, M.C. Coene, Characterization of an azole-resistant Candida glabrata isolate, Antimicrob. Agents Chemother. 36 (1992) 2602-2610.
28. S. Ansari, R. Prasad, Effect of miconazole on the structure and function of plasma membrane of Candida albicans, FEMS Microbiol. Lett. 114 (1993) 93-98.
29. D. Kerridge, Mode of action of clinically important antifungal drugs, Adv. Microbial Physiol. 27 (1986) 1-72.
30. J.L. Rodriguez-Tudela, J.V. Martinez-Suarez, Improved medium for fluconazole susceptibility testing of Candida albicans, Antimicrob. Agents Chemother. 38 (1994) 45-48.
31. M.S. Marriot, K. Richardson, The discovery and mode of action of fluconazole, in: R.A. Fromtling, J.R. Prous (Eds.), Recent Trends in the Discovery, Development and Evaluation of Antimicrobial Agents, Barcellona, 1987, pp. 81-92.
32. J.N. Galgiani, Susceptibility testing of fungi: current status of the standardization process, Antimicrob. Agents Chemother. 37 (1993) 2517-2521.
33. F.C. Odds, A.B. Abbott, G.W. Pye et al., Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azoles/antibiotics interaction, J. Med. Vet. Mycol. 24 (1986) 305-311.
34. H.R. Shmeeda, E.B. Golden, Y. Barenholz, Membrane lipids and aging, in: M. Shinitzky (Ed.), Biomembranes, Structural and Functional Aspects, VCH Balabam, Weinheim, 1994, pp. 1-82.
35. V. Strippoli, F.D. D'Auriu, N. Simonetti, Investigations of the activity by contact of miconazole sulfosalicylate, J. Chemother. 2 (1990) 371-376.
36. A. Retico, G. Apuzzo, N. Simonetti, The action of imidazole against bacteria, J. Chem. 1 (Suppl. 4) (1989) 235-237.
37. O. Shimokawa, H. Nakayama, Increased sensitivity of Candida albicans cells accumulating 14 α-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents, Antimicrob. Agents Chemother. 36 (1992) 1626-1629.
38. A. Obayashi, Actions of surface active agents upon lactic acid bacteria. The germicidal action and the effect on the permeability, J. Gen. Appl. Microbiol. 7 (1961) 233-242.
39. G.R. Dychdala, Surface-active agents: acid-anionic compounds, in: S.S. Block (Ed.), Disinfection, Sterilization and Preservation, III ed., Lea and Febiger, PA, 1983, pp. 330-334.
40. P. Mishra, J. Bolard, R. Prosad, Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast, Biochim. Biophys. Acta 1127 (1992) 1-14.
41. C. Pelletier, P. Bourlioux, J. Van Heijenoort, Effects of subminimal inhibitory concentrations of EDTA on growth of E. coli and the release of lipopolysaccharide, FEMS Microbiol. Lett. 117 (1994) 203-206.
42. J.F. Ryley, R.G. Wilson, K.J. Barret-Beer, Azole resistance in Candida albicans, Sabour Med. Vet. Mycol. 22 (1984) 53-63.